Selux Diagnostics
Jack Percoskie has a diverse financial background, with experience in various leadership roles in companies such as Selux Diagnostics, Unimacts Global, Enzymatics, and more. With a Bachelor of Science degree in Accounting from Merrimack College, Jack has held titles ranging from Finance Manager to Chief Financial Officer throughout their career.
Selux Diagnostics
Selux Diagnostics is developing a Next-Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital-acquired infections, and help combat the global antibiotic resistance epidemic.